Survival of high grade glioma patients depends on their age at diagnosis

Cancer Biology and Therapy

Volumn 8, Issue 18, 2009, Pages 1719-1721

  Casartelli, Gianluigi ^a   Dorcaratto, Alessandra ^a   Ravetti, Jean Louis ^a   Sola, Simona ^b   Vitali, Alessandro ^b   Merlo, Domenico Franco ^a   Frosina, Guido ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b SANTA CORONA HOSPITAL   (Italy)

Author keywords

Age; Brain tumors; Glioblastoma; Hazard; Micronuclei; Prognosis; Survival

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CONTROLLED STUDY; FEMALE; GLIOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MICRONUCLEUS; ONSET AGE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL;

EID: 73249143556     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.18.9209     Document Type: Article

References (20)

1. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008; 359:492-507. Erratum in: N Engl J Med 359:877.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352:987-96.
3. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol 2007; 170:1445-53.
4. Ueda R, Low KL, Zhu X, Fujita M, Sasaki K, Whiteside TL, et al. Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma. J Transl Med 2007; 5:68.
5. Sperduto CM, Chakravarti A, Aldape K, Burger P, Papermaster GB, Sperduto P. Twenty-year survival in glioblastoma: a case report and molecular profile. Int J Radiat Oncol Biol Phys 2009; In Press.
6. Casartelli G, Bonatti S, De Ferrari M, Scala M, Mereu P, Margarino G, et al. Micronucleus frequencies in exfoliated buccal cells in normal mucosa, precancerous lesions and squamous cell carcinoma. Anal Quant Cytol Histol 2000; 22:486-92.
7. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81.
8. Cox DR. Regression Models and Life-Tables (with Discussions). J R Stat Soc Ser B-Stat Methodol 1972; 34:187-220.
9. Murgia E, Ballardin M, Bonassi S, Rossi AM, Barale R. Validation of micronuclei frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case-control study. Mutat Res 2008; 639:27-34.
10. Mateuca RA, Roelants M, Iarmarcovai G, Aka PV, Godderis L, Tremp A, et al. hOGG1(326), XRCC1(399) and XRCC3(241) polymorphisms influence micronucleus frequencies in human lymphocytes in vivo. Mutagenesis 2008; 23:35-41.
11. Emdad L, Sarkar D, Su ZZ, Boukerche H, Bar-Eli M, Fisher PB. Progression elevated gene-3 (PEG-3) induces pleiotropic effects on tumor progression: modulation of genomic stability and invasion. J Cell Physiol 2005; 202:135-46.
12. Akudugu JM, Slabbert JP, Serafin A, Bohm L. Frequency of radiation-induced micronuclei in neuronal cells does not correlate with clonogenic survival. Radiat Res 2000; 153:62-7.
13. Driessens G, Harsan L, Robaye B, Waroquier D, Browaeys P, Giannakopoulos X, et al. Micronuclei to detect in vivo chemotherapy damage in a p53 mutated solid tumor. Br J Cancer 2003; 89:727-9.
14. Slowinski J, Mazurek U, Bierzynska-Macyszyn G, Widel M, Latocha M, Glogowska-Ligus J, et al. Cell proliferative activity estimated by histone H2B mRNA level correlates with cytogenetic damage induced by radiation in human glioblastoma cell lines. J Neurooncol 2005; 71:237-43.
15. Delfino V, Casartelli G, Garzoglio B, Scala M, Mereu P, Bonatti S, et al. Micronuclei and p53 accumulation in preneoplastic and malignant lesions of the head and neck. Mutagenesis 2002; 17:73-7.
16. Guzmán P, Sotelo-Regil RC, Mohar A, Gonsebatt ME. Positive correlation between the frequency of micronucleated cells and dysplasia in Papanicolaou smears. Environ Mol Mutagen 2003; 41:339-43.
17. Fazeny-Dörner B, Wenzel C, Veitl M, Piribauer M, Rössler K, Dieckmann K, et al. Survival and prognostic factors of patients with unresectable glioblastoma multiforme. Anticancer Drugs 2003; 14:305-12.
18. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003; 99:467-73.
19. Puduvalli VK, Hashmi M, McAllister LD, Levin VA, Hess KR, Prados M, et al. Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival. Oncology 2003; 65:259-66.
20. Rainov NG, Dobberstein KU, Bahn H, Holzhausen HJ, Lautenschläger C, Heidecke V, et al. Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival. J Neurooncol 1997; 35:13-28.